Clinical Trial Update: Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating effectiveness, safety, and health-related outcomes of NUEDEXTA in nursing home patients with pseudobulbar affect was terminated; result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudobulbar Affect

Drugs mentioned

• NUEDEXTA (DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE)

Snippet

Sponsor: Avanir Pharmaceuticals | Conditions: Pseudobulbar Affect (Involuntary Laughing and/or Crying) | Phase 4 | Status: TERMINATED | Results posted: 2017-07-03